EGFR and head and neck carcinoma: On the other hand, in head and neck carcinoma cells it was established that activation of CD44 in complex with the EGFR (epidermal growth factor receptor) signals the release of Ca2+ from the endoplasmic reticulum, leading to CaMK-II activation.